GHRP-6 10mg
GHRP-6 (Growth Hormone-Releasing Peptide-6) is a synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂) that acts as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a).
GHRP-6 (Growth Hormone-Releasing Peptide-6) is a synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂) that acts as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a).
Browse nearby entries from the full catalog, starting with Purchase Peptides.
Start with adjacent compounds, or send one straight to the assistant for a comparison prompt.
Ask AssistantGHRP-6 (Growth Hormone-Releasing Peptide-6) is a synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂) that acts as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a). It activates Gq protein and phospholipase-C signaling pathways, leading to calcium-dependent GH release in experimental models. GHRP-6 is used in research investigating the regulation of the pituitary, hypothalamic feedback mechanisms, and peptide-mediated endocrine signaling.
GHRP-6 is an effective stimulant of natural growth hormone release from the anterior pituitary gland. GHRP-6 is also a ghrelin/growth hormone receptor agonist and one of the few ghrelin analogs developed in the last few decades. It has been found to have positive effects on cardiac muscle cells, memory formation, scar formation, libido, and the neurons involved in Parkinson's disease. GHRP-6 is effective orally and sublingually and exhibits moderate to high selectivity.
Jump from this product into the newest URLs, recent updates, and grouped hubs.
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Synthetic fraction of the protein thymosin beta-4, used to investigate actin polymerization and cell migration in recovery contexts.
5-amino-1MQ is a small-molecule research compound that acts as a selective nicotinamide-N-methyltransferase (NNMT) inhibitor.
Acetyl Hexapeptide-3 (Argireline) is a hexapeptide analogue of SNAP-25 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂), developed to modulate vesicle docking and the release of catecholamines by inhibiting SNARE complex formation.
The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and what's changing in 2025-2026.
Comprehensive guide to BPC-157 dosing — injection, oral, and nasal protocols. How to reconstitute, calculate doses, and structure your cycle based on commonly reported approaches.
Supporting documents typically expected alongside the product profile.
This page is compiled from publicly available research material and normalized for browsing inside the catalog.